Skip to main content


Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Fig. 1 | BMC Psychiatry

Fig. 1

From: “Choose change”: design and methods of an acceptance and commitment therapy effectiveness trial for transdiagnostic treatment-resistant patients

Fig. 1

Illustration of the study design. Note. Smartphone, Heat Induction Test, Assessment is administered at Baseline, Post, and 12-month follow-up. Process assessment is assessed weekly during the intensive treatment phase by the patient, therapist, and nurse (in the case of the inpatient setting). Assessment through questionnaires and interview are administered at 1-, 4-, and 9-month follow up. BL: Baseline; P: Patient; T: Therapist; N: Nurse (only for the inpatient setting). FU-1, FU-4, FU-9, FU-12: Assessments at 1-, 4-, 9-, and 12-month follow up

Back to article page